Ophthalmoscopy Doctors Abroad — Page 6

Dr. Jacob Peer treats complex eye conditions at Hadassah Medical Center. His work includes ophthalmoscopy to evaluate internal eye health.

• Treats cataracts – a clouding of the eye lens
• Addresses cases of strabismus, where eyes do not align properly
• Specializes in surgical treatments for chronic ophthalmic conditions
• Uses clinical findings to improve outcomes for eye patients

Dr. Ulviye Askerova, MD, is an ophthalmologist. She earned her MD from Azerbaijan Medical University in 2019. She is completing an ophthalmology residency at Göztepe City Hospital / Istanbul Medeniyet University (2021–2025). Her clinical focus includes cataract surgery with intraocular lenses (including trifocal), medical retina, pediatric ophthalmology and strabismus, and oculoplastics.

She has two peer-reviewed international publications (Graefes Arch Clin Exp Ophthalmol, 2023; Medical Journal of Medeniyet, 2025). She has given four presentations at national and international meetings (ASO & TROS 2022; TOD 2023; TOD 2024; ASO & TROS 2024).

She completed the TOD Vitreoretinal Surgery Unit “Basic Techniques in Vitreoretinal Surgery” Skills Transfer Course in May 2024. She has participated in nine congresses, symposia, and webinars from 2022 to 2025, including the TOD National Congresses (56th and 57th) and the 9th TOD Live Surgery Symposium.

Professor Martin Zehetmayer is a senior surgeon at Döbling Private Hospital. He specializes in eye tumors and complex cataract surgery using ophthalmoscopy for precise evaluation.

• Authored around 100 scientific papers in specialized medical journals
• Leads the outpatient clinic for eye tumors in Vienna
• President of the Vienna Ophthalmological Society
• Developed stereotactic radiation therapy for malignant eye tumors
• Pioneered new intraocular lens technologies and corneal research

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

Dr. Stefan Sacu specializes in retinal and macular disease at Vienna General Hospital. He uses ophthalmoscopy to evaluate complex retinal vein occlusions and vitreous body destruction.

• Lecturer in practical ophthalmology at the Medical University of Vienna since 2001
• Performs mutation analysis to identify specific genetic causes for retinal dystrophies
• Uses electrophysiological methods to measure electrical responses of eye cells to light
• Winner of the Theodor-Koerner Science Prize for his significant research contributions
• Member of the European Society of Cataract and Refractive Surgeons (ESCRS)

Professor Schmidt-Erfurth heads the Ophthalmology Department at Vienna General Hospital. She leads eye care at one of Europe's largest medical centers.

• Specializes in ophthalmoscopy to detect retina and optic nerve disorders
• Directs the clinical department for ophthalmology and optometry
• Conducts research at the Medical University of Vienna
• Oversees diagnostic eye protocols at a major university teaching hospital

Professor Georgopoulos is a senior consultant at the Medical University of Vienna. He provides expert consultations and ophthalmoscopy at Döbling Private Hospital.

• Specializes in using high-resolution 3D optical coherence tomography for detailed retinal imaging
• Treats complex surgical diseases of the macula, retina, and vitreous body
• Performs combined surgeries to treat cataracts and retinal issues in one session
• Conducts clinical research on seamless vitrectomy and protein-dissolving drug therapies
• Holds the title of Professor of Ophthalmology at the Medical University of Vienna

Professor Martin Zehetmayer heads the Eye Clinic at Vienna General Hospital. He uses ophthalmoscopy to help identify and treat rare eye tumors.

• Pioneered stereotactic radiation therapy for malignant choroid tumors to help preserve vision
• Authorized approximately 100 scientific papers on ophthalmic oncology and cataract surgery
• Former President of the Vienna Ophthalmological Society
• Leads the outpatient clinic for eye tumors at a major university hospital
• Appointed as University Professor at the University of Ophthalmology and Optometry

Dr. Pak Jongbeom is the Chief of Ophthalmology at Naeun Hospital. He focuses on retinal and vitreous diseases, such as uveitis and macular degeneration. He also treats general ophthalmology conditions, including cataract and glaucoma.

Education and training: M.D., Kyung Hee University Graduate School of Medicine. Internship, ophthalmology residency, and fellowship at Kyung Hee University Medical Center.

Accreditations: Full Member, Korean Ophthalmological Society. Regular member, American Society of Retina Specialists, EURETINA, Asia-Pacific Vitreo-Retina Society, and Asia-Pacific Retina Ophthalmic Imaging Society.

Publications: Park JB et al., J Korean Ophthalmol Soc. 2021;62(1):109-13. 2021;62(6):762-8. Park JB et al., Taiwan J Ophthalmol. 2022;12:394-408.

Dr. Helvacıoğlu has performed over 20,000 surgeries at Veni Vidi Eye Clinics. He is board-certified by the International Council of Ophthalmology after passing selective science exams.

• Specializes in ophthalmoscopy for vitreous body destruction and retinal detachment care
• Performs vitrectomy – a delicate procedure to remove and replace eye fluid
• Uses femtosecond lasers to create precise incisions with ultrashort pulses
• Member of the European Society of Cataract and Refractive Surgeons
• Completed his specialist residency at Bakirkoy Dr. Sadi Konuk Training Hospital

With 45,000 surgeries performed, Dr. Sutan Kaya is a senior specialist at Veni Vidi Eye Clinics. His ophthalmoscopy evaluations support complex surgical planning for cataracts and retina detachment.

• Member of the American Academy of Ophthalmology, a world-leading body for eye care standards
• Specializes in corneal topography analyzing to map the surface of the eye
• Certified in femtosecond laser applications for precise anterior segment procedures
• Uses multifocal intraocular lenses to correct age-related blurry near vision
• Experienced in treating glaucoma and amblyopia, commonly known as lazy eye

Dr. Ulrich Schaller serves as the personal physician to the President of Turkmenistan. He leads a private practice at the Herzog Carl Theodor Eye Clinic in Munich. The clinic reports a 99.8% success rate for cataract treatments. Dr. Schaller specializes in laser vision correction and complex retinal diseases. He treats both adults and children for conditions like glaucoma and strabismus.

• Performs LASIK, PRK, and ReLEx SMILE for refractive errors.
• Expert in cataract surgery with multifocal lens implants.
• Conducts corneal transplants and laser treatments with Argon and YAG lasers.
• Speaker at the German Ophthalmological Society and the Academy of Germany.

Dr. Mehmet Orçun Akdemir is an ophthalmologist at Veni Vidi Eye Clinics in Istanbul. He specializes in cornea treatments, including keratoconus management and complex keratoplasty procedures. He is a member of the Turkish Ophthalmology Association. Dr. Akdemir works at an ISO 9001 certified center that treats 50,000 patients annually.

• Published over 40 articles in national and international peer-refereed journals.
• Expert in DALK, PKP, and DSAEK corneal transplant techniques.
• Performs glaucoma surgery, including trabeculectomy and Ahmed valve implantation.
• Translated four medical textbooks on ophthalmology and glaucoma care.

Professor Peykan Türkçüoğlu completed clinical training at Johns Hopkins Hospital. He performs ophthalmoscopy to detect retina and vitreous body conditions at Veni Vidi Eye Clinics.

• Fellow at the Wilmer Eye Institute – a global leader in ophthalmology research
• Faculty member at Biruni University – teaches advanced eye surgery to medical students
• Expert in vitreoretinal treatment – treats retinal detachment using specialized microsurgery
• Performs keratoplasty – utilizes donor tissue to replace damaged corneas and restore vision
• Specializes in glaucoma and macular dystrophy treatments using laser therapies